Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mojisola O. Araoye"'
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e27-e40
A subset of individuals with smoldering myeloma (SMM) are at a high risk of progression to symptomatic myeloma. Current efforts are focused on identifying this high-risk group and intercepting the disease process before its progression. There is no c
Autor:
Ademola S. Ojo, Somtochukwu G. Ojukwu, Joseph Asemota, Oluwasegun Akinyemi, Mojisola O. Araoye, Mohammed Saleh, Ahmed Ali, Ravi Sarma
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:897-911
Smoldering multiple myeloma (SMM) is an intermediate pre-malignant condition with individuals having a distinct risk of progression to overt myeloma. The optimal management option has remained controversial due to the heterogeneous nature of the cond
Publikováno v:
Journal of Cancer Survivorship.
Publikováno v:
Cancer epidemiology. 79
Although the incidence of cancers is on the rise globally, mortality has continued to decrease due to advances in early detection and treatment. Cancer treatments such as chemotherapy and radiotherapy can impact the reproductive capacity of survivors
Autor:
Mojisola O Araoye, Brian J. Byrne
Publikováno v:
Journal of Clinical Oncology. 38:74-74
74 Background: Immunotherapy is a type of cancer treatment that uses an individual’s immune system to fight cancer. Most clinical trials involving immunotherapy have been done on healthy patients, thus excluding many hospitalized patients. Many onc
Publikováno v:
Journal of Cancer Survivorship; Jun2024, Vol. 18 Issue 3, p673-697, 25p
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; Jan2023, Vol. 23 Issue 1, pe27-e40, 14p, 3 Diagrams, 3 Charts
Publikováno v:
Stem Cell Week; 11/12/2024, p1783-1783, 1p
Autor:
Ojo, Ademola S., Ojukwu, Somtochukwu G., Asemota, Joseph, Akinyemi, Oluwasegun, Araoye, Mojisola O., Saleh, Mohammed, Ali, Ahmed, Sarma, Ravi
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Apr2022, Vol. 148 Issue 4, p897-911, 15p
Publikováno v:
Stem Cell Week; 3/2/2023, p367-367, 1p